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Abstract
Background: The importance of rehabilitation therapy in Parkinson’s disease is
well recognized. However, the effects of an inpatient rehabilitation program for
advanced Parkinson’s disease have not been fully investigated.
Aim: To assess the effects of intensive inpatient rehabilitation.
Methods: We enrolled 31 patients (mean age 69.5  9.4 years; mean disease dura-
tion 8.8  6.4 years) with advanced Parkinson’s disease, without severe cognitive
impairment. The median Hoehn–Yahr stage was IV. Patients received 2 h of indi-
vidualized rehabilitation for 6–7 days each week for 1 month. At hospital dis-
charge, patients and caregivers were instructed to continue daily exercise.
Results: Motor and total scores of Functional Independence Measures signifi-
cantly improved between admission and discharge in patients with stage III and
IV disease, but not stage V. There was no significant effect of Hoehn–Yahr stage
on improvements in Unified Parkinson’s Disease Rating Scale scores, (total, part I,
II or III), cognitive Functional Independence Measures or Berg Balance Scale.
Conclusion: Intensive inpatient rehabilitation was effective even in advanced Parkin-
son’s disease. Intensive inpatient rehabilitation, together with home and day-care
exercise, might counteract the progressive motor decline in Parkinson’s disease.
Introduction
Because of the aging of populations in some countries, Parkin-
son’s disease (PD) has become increasingly prevalent. Despite
significant advances in medical treatments, patients with PD
experience a gradual decline in mobility, which is especially
problematic in the advanced stages. Other serious complica-
tions that commonly occur in advanced PD include pneumonia
and bone fracture.1,2 Although the symptoms of PD are pro-
gressive, non-pharmacological strategies, such as patient reha-
bilitation programs, have been reported to be effective.3–5
Rehabilitation therapy aims to preserve motor function,
and lower the risk of complications, including falls, respira-
tory infections and disuse syndrome. It might also slow the
progression of motor disability and improve patients’
prognosis.4,5
The purpose of the present study was to assess the effects
of intensive inpatient rehabilitation for PD.
Methods
Patients. Between April 2008 and December 2015, 114
patients with PD were admitted to Hiroshima City
Rehabilitation Hospital, Hiroshima City, Hiroshima, Japan.
All patients had received neurological treatment at outpa-
tient clinics and were referred to our hospital for intensive
rehabilitation therapy as a result of worsening symptoms.
We excluded patients with complications, including bone
fracture, pneumonia, stroke and psychotic symptoms. We
also excluded patients with severe cognitive dysfunction who
were unable to comply with the rehabilitation protocol. To
evaluate the effects of non-pharmacological rehabilitation
therapy, we analyzed clinical data for those patients whose
medical treatment had not been adjusted. As a result,
patients at Hoehn–Yahr (H-Y) stage I or II were excluded.
We recruited 31 patients (15 men, 16 women) to participate
in the study. The mean age and standard deviation (SD) of
patients was 69.5  9.4 years. Diagnoses of idiopathic PD
were confirmed by certified neurologists. The mean duration
of disease was 8.8  6.4 years. The median H-Y stage was IV
(with seven at stage III, 18 at stage IV and six at stage V).
Mini-Mental State Examination (MMSE) scores ranged from
16 to 30, with a mean of 25.3  6.3.
Written informed consent was obtained from all patients
before inclusion. This study was approved by the ethical
committee of Hiroshima City Rehabilitation Hospital.
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Intervention. Conventional group rehabilitation is
offered in an outpatient setting. However, in the present
study, intensive rehabilitation was provided to inpatients on
an individual basis. A total of 25 patients received 2 h of
individual therapy for 6 days per week. The remaining six
patients received therapy 7 days per week. The increase
from 6 to 7 days of therapy was made after changes to the
medical administration policy in April 2014.
Physical therapy was carried out, and aimed to improve
mobility, posture, balance, muscle strength and range of
joint motion. This was accompanied by auditory and visual
cue training. Occupational therapy for activities of daily liv-
ing (ADL) and hand functionality was provided. Speech
therapy was carried out to improve vocal intensity, vocal
quality and fluency, with music therapy carried out with
some patients. The mean length of hospital stay was
29.2  7.0 days.
After discharge from hospital, patients and their family
members were instructed that patients should carry out indi-
vidually tailored exercises at home for 20–60 min each day.
Patients were also advised on fall prevention, feeding and
care procedures.
To ensure that care insurance would cover the cost of the
rehabilitation services, care conferences were held with
patients, family members, caregivers, rehabilitation thera-
pists and care managers before discharge from hospital.
Outcome measures. Patients were evaluated at admis-
sion and discharge from hospital. Motor function was
assessed using the Unified Parkinson’s Disease Rating Scale
(UPDRS) Part III and the Berg Balance Scale (BBS). ADL
were assessed using the UPDRS Part II and Functional
Independence Measures (FIM) scores. The FIM was evalu-
ated by nurses and therapists, BBS by physical therapists,
and UPDRS by rehabilitation therapists and neurologists.
In patients with “on–off” phenomenon, BBS was evaluated
during “on” intervals. The measures were checked and con-
firmed during the clinical conference.
Statistical analysis. We analyzed the effects of intensive
inpatient intervention by comparing clinical parameters at
admission (adm) with those at discharge (disch) in relation
to H-Y stage. We carried out a two-way analysis of variance
(ANOVA) (adm/disch 9 H-Y) with repeated measures, fol-
lowed by Fisher’s pairwise comparison.
We carried out a one-way ANOVA with Fisher’s pairwise
comparison to investigate differences between the three H-Y
subgroups (stages III, IV and V) in age, duration of disease
and MMSE scores. Statistical significance was set at
P < 0.05.
All statistical analyses were carried out using Ekuseru–
Toukei 2012 software (Social Survey Research Information,
Tokyo, Japan).
Results
The characteristics of patients at admission to hospital and
outcome measures are presented according to H-Y stage
(Table 1). Table 2 shows the results of the two-way ANOVA
with repeated measures. The factor effect of intervention
(adm/disch) was significant for all parameters, except
UPDRS Part IV. The interaction between intervention and
disease severity (adm/disch 9 H-Y) was significant for
motor and total FIM scores. The result of each paired com-
parison suggests that motor and total FIM scores were sig-
nificantly higher after 1 month in stage III and stage IV
patients (P < 0.05), but not in stage V patients (Table 1).
Discussion
The present results show that intensive inpatient rehabilita-
tion therapy was associated with improved motor function
in advanced PD, with substantial improvements in FIM for
H-Y stages III and IV.
Most rehabilitation strategies for PD focus on group
training programs in outpatient clinics and home exercise
routines at relatively early stages of the disease. A systemic
Table 1 Patients’ backgrounds and outcome measures
H-Y III (n = 7) IV (n = 18) V (n = 6)
Sex (male/female) 5/2 8/10 2/4
Age (years) 63.1  14.9 70.4  6.5 74.3  6.2
Duration of illness (years) 4.6  2.5 9.6  6.4 14.3  8.2
MMSE 26.9  2.5 25.1  5 23.0  12.3
Adm Disch Adm Disch Adm Disch
Motor FIM 52.0  14.3 63.0  13.8* 47.2  13.5 56.3  14.3* 30.5  10.6 30.7  9.3
Cognitive FIM 26.0  4.2 27.6  3.1 25.0  5.1 27.2  5.1 21.7  8.3 22.5  7.1
Total FIM 78.0  16.6 90.6  15.6* 72.3  18.0 83.5  18.8* 52.2  15.2 53.2  13.0
UPDRS Part I 1.7  1.9 1.7  1.9 2.5  2.6 2.3  2.4 3.0  2.9 2.4  2.3
UPDRS Part II 17.0  4.7 15.7  4.8 21.3  7.1 19.8  6.5 27.6  5.7 26.2  7.1
UPDRS Part III 34.5  11.4 31.8  11.3 41.7  14.5 37.8  15.3 49.8  17.0 49.0  17.6
UPDRS Part IV 0.2  0.4 0.2  0.4 1.5  1.7 1.2  1.3 2.4  2.6 2.0  1.7
UPDRS total 53.3  16.6 49.7  17.1 66.6  22.2 61.2  22.6 82.6  17.4 79.6  19.6
BBS 40.0  10.6 47.4  8.7 27.0  10.9 32.2  10.3 11.3  9.0 15.3  10.5
Adm, admission; BBS, Berg Balance Scale; Disch, discharge; FIM, Functional Independence Measures; UPDRS, Unified Parkinson’s Disease
Rating Scale.
Data presented as mean  SD. *P < 0.05.
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review reported that in 50 of 51 studies included, rehabilita-
tion interventions delivered at patients’ homes or in outpa-
tient clinics were associated with an improvement in at least
one outcome measure compared with control interventions
or no intervention.3 Another meta-analysis of studies evalu-
ating the effects of physical therapy on PD reported a signif-
icant improvement in ADL and stride length, but not in
neurological signs.6
Because motor symptoms gradually progress in PD, it is
important to evaluate the long-term benefits of rehabilita-
tion therapy. Sturkenboom et al.7 reported that 10 weeks of
home-based, individualized occupational therapy led to an
improvement in self-perceived performance in daily activi-
ties, which was maintained 3 months after therapy. Con-
versely, in patients with PD with H-Y stage II–III, UPDRS,
ADL and motor scores were significantly improved by a 4-
week intensive physical rehabilitation program, but had
returned to baseline 6 months later without regular exer-
cise.8 Such results suggest that motor disabilities are objec-
tively improved by a regular program of physical
rehabilitation, but improvements cannot be sustained with-
out continued exercise after the program.
With respect to moderate and advanced PD, the short-
and long-term effects of inpatient rehabilitation in patients
at H-Y stage III have been previously described.9,10 Motor
function improved after 4 weeks of inpatient physical ther-
apy, comprising three sessions of 1 h for 5 days each week,
with total UPDRS and BBS scores changing from 40 to 289
and 45.1 to 50.8,10 respectively. After daily home exercises
for the subsequent year, total UPDRS and BBS scores were
419 and 45.5,10 respectively. This suggests that motor func-
tion was mostly preserved. Furthermore, the daily medica-
tion dosage was reduced, and the second rehabilitation cycle
administered after 1 year was as effective as the first inter-
vention.9 These findings suggest that rehabilitative interven-
tions might counteract the progressive worsening of
symptoms. Interestingly, in patients with Parkinson’s at H-
Y stages I–IV, lower motor function at baseline was associ-
ated with a greater response to intensive inpatient rehabilita-
tion over 6 weeks.11 The present study showed that patients
at H-Y stage V did not show significant improvements in
FIM score. Insufficient therapeutic effects of rehabilitation
might be linked to a higher frequency of complications,
including joint contracture, sarcopenia and disuse syndrome.
Additionally, the mean MMSE score in patients at H-Y
stage V was below the optimal diagnostic cut-off (MMSE
24/25) for cognitive disorders in PD.12 The lower cognitive
function of these patients might have contributed to the dif-
ference in outcome after intensive rehabilitation. The present
findings show that intensive rehabilitation is particularly
important during stages III–IV of PD. At this stage, it can
counteract symptomatic progression by preventing disuse
syndrome and lowering the risk of severe complications,
such as aspiration pneumonia or bone fractures.
A previous study has shown the effectiveness of a 6-
month education and health promotion program in patients
with PD. Patients delivered the intervention had a plateau
in summary scores of their progression rate, a slight
decrease in levodopa dose, and a reduction in number of
doctor visits, hospital days and sick days compared with
patients not receiving an active intervention.13 The authors
concluded that a low-cost patient education program might
be a useful adjunct to pharmacotherapy for PD, and could
improve midterm outcomes.
The limitations of the present study were largely similar
to those of previously reported studies.4,9 The lack of a con-
trol group and the small sample size were the key disadvan-
tages.4,9 Another concern was patient compliance with home
exercise programs.9 Randomized controlled trials with a
large sample size are required to verify the role of individu-
alized, intense rehabilitation programs. Furthermore, multi-
center studies will be required to assess the cost-effectiveness
and long-term effects of rehabilitation programs on the
functionality and quality of life of patients with PD.
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